期刊
NANOMEDICINE
卷 6, 期 4, 页码 747-755出版社
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.11.55
关键词
insurance; nanomedicine; nanotoxicology; patents; profitability; public education; regulation
The future of nanomedicines is undermined by the lack of financial profitability, consumer distrust, ineffective regulation of new and generic products, weak patent protection and insurance market failure. Its economic breakthrough is dependent on a series of countervailing measures and actions. Success requires more investment induced by cost effectiveness analyses and business plans based on clinical data, public education based on nanotoxicology studies, smart regulatory reform in the areas of testing, market entry and liability, effective and strategic patenting, patent dispute prevention and resolution, and innovative insurance policies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据